The study confirmed that CPT1C is a novel target gene of PPARα, and that knockout of PPARα leads to a decrease in CPT1C expression, which inhibits the proliferation of MDA-MB-1 and PANC-1 tumor cell lines in a CPT1C-dependent manner (Chen et al., 2017a). This evidence concerns the gene PPARA and neoplasm.